8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid,2-[3-[2-(furanylmethyl)thio]-1-oxopropyl]hydrazide (SC-51322): A potent PGE2 antagonist and analgesic
- 10 February 1994
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 4 (3), 509-514
- https://doi.org/10.1016/0960-894x(94)80027-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effects of systemic non-steroidal anti-inflammatory drugs on nociception during tail ischaemia and on reperfusion hyperalgesia in ratsBritish Journal of Pharmacology, 1992
- Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea‐pig ileumBritish Journal of Pharmacology, 1992
- The mechanisms of action of nonsteroidal antiinflammatory drugsArthritis & Rheumatism, 1989
- Characterization of the arachidonic acid metabolites mediating bradykinin and noradrenaline hyperalgesiaBrain Research, 1988
- Hyperalgesia onset latency suggests a hierarchy of actionBrain Research, 1987
- The antinociceptive effects of prostaglandin antagonists in the ratEuropean Journal of Pharmacology, 1987
- Peripheral neural mechanisms of cutaneous hyperalgesia following mild injury by heatJournal of Neuroscience, 1982
- Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic effectNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1976
- Prostaglandins and the mechanism of analgesia produced by aspirin‐like drugsBritish Journal of Pharmacology, 1973
- The National Research Centre for Disaster PreventionNature, 1972